A detailed history of California State Teachers Retirement System transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 60,905 shares of COGT stock, worth $587,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,905
Previous 62,945 3.24%
Holding current value
$587,733
Previous $530,000 23.96%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$8.24 - $11.48 $16,809 - $23,419
-2,040 Reduced 3.24%
60,905 $657,000
Q2 2024

Aug 14, 2024

SELL
$6.01 - $9.04 $8,450 - $12,710
-1,406 Reduced 2.18%
62,945 $530,000
Q1 2024

May 15, 2024

BUY
$4.38 - $9.02 $38,561 - $79,412
8,804 Added 15.85%
64,351 $432,000
Q4 2023

Feb 13, 2024

SELL
$4.06 - $10.08 $41,777 - $103,723
-10,290 Reduced 15.63%
55,547 $326,000
Q3 2023

Nov 14, 2023

SELL
$9.69 - $13.34 $46,686 - $64,272
-4,818 Reduced 6.82%
65,837 $641,000
Q2 2023

Aug 21, 2023

BUY
$9.85 - $13.24 $159,116 - $213,878
16,154 Added 29.64%
70,655 $836,000
Q1 2023

May 09, 2023

BUY
$10.04 - $15.5 $3,875 - $5,983
386 Added 0.71%
54,501 $588,000
Q4 2022

Feb 14, 2023

BUY
$10.65 - $14.84 $307,060 - $427,866
28,832 Added 114.04%
54,115 $625,000
Q3 2022

Nov 18, 2022

BUY
$9.39 - $16.99 $58,302 - $105,490
6,209 Added 32.55%
25,283 $377,000
Q2 2022

Aug 15, 2022

BUY
$3.92 - $9.73 $12,442 - $30,883
3,174 Added 19.96%
19,074 $172,000
Q1 2022

May 16, 2022

SELL
$5.31 - $8.7 $22,084 - $36,183
-4,159 Reduced 20.73%
15,900 $119,000
Q3 2021

Nov 15, 2021

SELL
$5.99 - $9.14 $187,187 - $285,625
-31,250 Reduced 60.91%
20,059 $169,000
Q2 2021

Aug 16, 2021

BUY
$7.82 - $9.3 $401,236 - $477,173
51,309 New
51,309 $416,000

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $635M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.